These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17073649)

  • 1. Identifying accessible sites in RNA: the first step in designing antisense reagents.
    Pan WH; Clawson GA
    Curr Med Chem; 2006; 13(25):3083-103. PubMed ID: 17073649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to identify potential therapeutic target sites in RNA.
    Lützelberger M; Kjems J
    Handb Exp Pharmacol; 2006; (173):243-59. PubMed ID: 16594619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells.
    Dutkiewicz M; Ojdowska A; Kuczynski J; Lindig V; Zeichhardt H; Kurreck J; Ciesiołka J
    PLoS One; 2015; 10(8):e0136395. PubMed ID: 26308932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition.
    Pierce ML; Ruffner DE
    Nucleic Acids Res; 1998 Nov; 26(22):5093-101. PubMed ID: 9801305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a new concept of gene inactivation: specific RNA cleavage by endogenous ribonuclease P.
    Hartmann RK; Krupp G; Hardt WD
    Biotechnol Annu Rev; 1995; 1():215-65. PubMed ID: 9704090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA as a target for developing antivirals.
    McKnight KL; Heinz BA
    Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for prediction of accessible sites on an mRNA sequence for target selection of hammerhead ribozymes.
    Mercatanti A; Rainaldi G; Mariani L; Marangoni R; Citti L
    J Comput Biol; 2002; 9(4):641-53. PubMed ID: 12323098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches for the sequence-specific knockdown of mRNA.
    Scherer LJ; Rossi JJ
    Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native mRNA antisense-accessible sites library for the selection of antisense oligonucleotides, PNAs, and siRNAs.
    Fang H; Shen Y; Taylor JS
    RNA; 2010 Jul; 16(7):1429-35. PubMed ID: 20498459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical and experimental approaches to design effective antisense oligonucleotides.
    Sczakiel G
    Front Biosci; 2000 Jan; 5():D194-201. PubMed ID: 10702382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design of antisense RNA.
    Sczakiel G
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):439-44. PubMed ID: 9303196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide scanning arrays: application to high-throughput screening for effective antisense reagents and the study of nucleic acid interactions.
    Sohail M; Southern EM
    Adv Biochem Eng Biotechnol; 2002; 77():43-56. PubMed ID: 12227736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selection system for identifying accessible sites in target RNAs.
    Pan WH; Devlin HF; Kelley C; Isom HC; Clawson GA
    RNA; 2001 Apr; 7(4):610-21. PubMed ID: 11345439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.
    Wrzesinski J; Legiewicz M; Ciesiołka J
    Nucleic Acids Res; 2000 Apr; 28(8):1785-93. PubMed ID: 10734198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets.
    Jarad G; Simske JS; Sedor JR; Schelling JR
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):415-21. PubMed ID: 12815338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of hammerhead flanking sequences using oligonucleotide facilitators.
    Goodchild J
    Methods Mol Biol; 1997; 74():265-73. PubMed ID: 9204441
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.